Investseekers, citing MedWatch, says the new version carries three times the semaglutide of the current 2.4 mg Wegovy dose.
Recap by typeshit. Post by Investseekers on X.
A short Facebook share with no context on who used the peptides, where it happened or what followed.
Benzinga notes a 1.89% after-hours gain for Lilly stock, with Novo Nordisk also tagged. No further detail on what drove the move.
Mikhail Varshavski tells Fox News why protein matters, especially for GLP-1 users. He has a paid partnership with Quest Nutrition.
2:07:50
A live Q&A session covering GLP-1 drugs including Zepbound, Wegovy and Foundayo, with the host taking questions from viewers.
A brand account notes that eating less on a GLP-1 can make it harder to get enough nutrients. General advice with no new details.
A user says energy drops as their dose rises and eating protein gets harder, and asks others how they manage workouts and meals.
Loading…